S1 File - حسب Valérie Chetboul (579758)

الموضوعات:

Number of Doppler examinations (i.e., 1, 2, or 3) that allowed the board-certified specialist (VC) in charge of the French cardiovascular breed screening program (2010–2023) to con... حسب Valérie Chetboul (579758)

الموضوعات:

Growth of Sf14 in various media. حسب Nykki D. Ross (20933968)

Growth of Sf14 in various media and temperatures. حسب Nykki D. Ross (20933968)

Growth of bacteria in various media and temperatures with or without Sf14 infection. حسب Nykki D. Ross (20933968)

Growth of bacteria in various media and temperatures with or without Sf14 infection. حسب Nykki D. Ross (20933968)

Flow Chart of Study Participant Selection. حسب Zhi Jin (3742471)

"…Notably, individuals with long sleep duration (>9 hours) had a significantly decreased risk of CVD (OR: 0.36, 95% CI: 0.15–0.85, P = 0.02) compared to those with shorter sleep durations.…"

Innovation and night light in large and small cities. حسب Saul Estrin (8629173)

Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance حسب Qiu Fu (10830823)

"…Quite encouragingly, the incorporation of Au³⁺ facilitates films in achieving desirable flame retardancy, evidenced by a significant increase in the limiting oxygen index from 19.2% to 39.2%. …"

Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance حسب Qiu Fu (10830823)

"…Quite encouragingly, the incorporation of Au³⁺ facilitates films in achieving desirable flame retardancy, evidenced by a significant increase in the limiting oxygen index from 19.2% to 39.2%. …"

Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance حسب Qiu Fu (10830823)

"…Quite encouragingly, the incorporation of Au³⁺ facilitates films in achieving desirable flame retardancy, evidenced by a significant increase in the limiting oxygen index from 19.2% to 39.2%. …"

Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance حسب Qiu Fu (10830823)

"…Quite encouragingly, the incorporation of Au³⁺ facilitates films in achieving desirable flame retardancy, evidenced by a significant increase in the limiting oxygen index from 19.2% to 39.2%. …"

Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"